ISPE releases new publication
The guide aims to offer a consistent interpretation of the latest FDA and EMA guidance.
Author
Glenmark to begin phase 2b clinical trial of atopic dermatitis drug
The company is also evaluating the potential for conducting studies with GBR 830 for the treatment of other inflammatory…
Crane to inaugurate Saunders HC4 aseptic diaphragm valve factory in Satara
Customers and industry stakeholders will participate in a day-long event complete with a tour of the new plant and visit Maher…
CBCC Global Research to introduce medical writing
CBCC Global Research sets the benchmark for medical services with its principle pattern of working with the client and other such…
SAC ACCP to organise 11th Annual International Conference in Mumbai
The theme for this year's conference is 'Clinical pharmacology contributing to Global Health and Policies
BioAscent establishes integrated drug discovery services offering
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences
GSK slims portfolio with sale of rare disease gene therapy drugs
The company divests its rare disease gene therapy drugs to Orchard Therapeutics
Sanofi to invest 350 million euros in Canada vaccine facility
The new facility would allow its Sanofi Pasteur division to meet the growing demand of five-component acellular pertussis (5-acP)…
Strides Shasun arm gets US FDA nod for allergy relief drug
The drug will be manufactured at its oral dosage facility at Bengaluru and will be marketed by Strides Pharma in the US
Sundyota Numandis launches anti-diarrhoea probiotic
The company has entered into a strategic partnership with Italian firm Probiotical